Breaking News

Bavarian Nordic Gets $539M BARDA Contract for Smallpox Vaccine

Will invest $75mn in the construction of a fill/finish mfg. line at its facility in Denmark

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Bavarian Nordic A/S was awarded a sole source contract from the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services (HHS), for the procurement of freeze-dried Imvamune smallpox vaccine. The potential value of the initial base and optional awards is in excess of $539 million. The initial award in the contract calls for the manufacturing and storage of $100...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters